Skip to main content
. Author manuscript; available in PMC: 2018 Oct 17.
Published in final edited form as: Am J Infect Control. 2018 Jan 9;46(6):649–655. doi: 10.1016/j.ajic.2017.11.018

Figure 2:

Figure 2:

Summary of Samples Analyzed by FDA Laboratories

Note: Several products from multiple manufacturers were initially tested for contamination. As docusate samples from Manufacturer X began testing positive for Bcc, more docusate samples were collected and tested. This led to docusate forming a higher proportion of samples tested.